中文版 | English
Title

Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development

Author
Corresponding AuthorWu, Weihui; Li, Liang; Bai, Fang
Publication Years
2023-02-21
DOI
Source Title
ISSN
1664-3224
Volume14
Abstract
COVID-19 pandemic continues to spread throughout the world with an urgent demand for a safe and protective vaccine to effectuate herd protection and control the spread of SARS-CoV-2. Here, we report the development of a bacterial vector COVID-19 vaccine (aPA-RBD) that carries the gene for the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Live-attenuated strains of Pseudomonas aeruginosa (aPA) were constructed which express the recombinant RBD and effectively deliver RBD protein into various antigen presenting cells through bacterial type 3 secretion system (T3SS) in vitro. In mice, two-dose of intranasal aPA-RBD vaccinations elicited the development of RBD-specific serum IgG and IgM. Importantly, the sera from the immunized mice were able to neutralize host cell infections by SARS-CoV-2 pseudovirus as well as the authentic virus variants potently. T-cell responses of immunized mice were assessed by enzyme-linked immunospot (ELISPOT) and intracellular cytokine staining (ICS) assays. aPA-RBD vaccinations can elicit RBD-specific CD4(+)and CD8(+)T cell responses. T3SS-based RBD intracellular delivery heightens the efficiency of antigen presentation and enables the aPA-RBD vaccine to elicit CD8(+)T cell response. Thus, aPA vector has the potential as an inexpensive, readily manufactured, and respiratory tract vaccination route vaccine platform for other pathogens
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
Corresponding
Funding Project
National Natural Science Foundation of China["31870130","31970680","31970179","32170199","82061148018"] ; National Key Research and Development Project of China["2021YFE0201300","2021YFE0101700"] ; National Research Foundation of Korea[NRF-2020K2A9A2A11102267]
WOS Research Area
Immunology
WOS Subject
Immunology
WOS Accession No
WOS:000943461400001
Publisher
Data Source
Web of Science
Citation statistics
Cited Times [WOS]:0
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/513449
DepartmentSchool of Medicine
Affiliation
1.Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Mol Microbiol, Tianjin, Peoples R China
2.Shenzhen Ctr Dis Control & Prevent, Dept Pathogen Biol, Shenzhen, Peoples R China
3.Peking Univ, Shenzhen Hosp, Intervent & Cell Therapy Ctr, Shenzhen, Peoples R China
4.Peking Univ, Hong Kong Univ Sci, Technol Med Ctr, Shenzhen, Peoples R China
5.Southern Univ Sci & Technol, Sch Med, Dept Pharmacol, Shenzhen, Peoples R China
6.Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea
Corresponding Author AffilicationSchool of Medicine
Recommended Citation
GB/T 7714
Zhou, Yuchen,Qu, Jing,Sun, Xiaomeng,et al. Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development[J]. Frontiers in Immunology,2023,14.
APA
Zhou, Yuchen.,Qu, Jing.,Sun, Xiaomeng.,Yue, Zhuo.,Liu, Yingzi.,...&Bai, Fang.(2023).Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development.Frontiers in Immunology,14.
MLA
Zhou, Yuchen,et al."Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development".Frontiers in Immunology 14(2023).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Zhou, Yuchen]'s Articles
[Qu, Jing]'s Articles
[Sun, Xiaomeng]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Zhou, Yuchen]'s Articles
[Qu, Jing]'s Articles
[Sun, Xiaomeng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhou, Yuchen]'s Articles
[Qu, Jing]'s Articles
[Sun, Xiaomeng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.